Applied Materials, Inc.
Sells chipmakers a broad tool set spanning deposition, ion implant and process control, plus display manufacturing equipment.
Trim AMAT to 50% of benchmark weight immediately given cycle-peak configuration (record Q3'26 revenue $9.12B, 33.7% operating margins, 41% TTM ROE) paired with decaying momentum and unsupportive macro conditions (96% probability of no 2026 Fed cuts, multi-year high yields). Maintain 50% residual with hard stop at $489 (50 SMA), and do not initiate fresh longs until either a cyclical reset to $415-432 zone or confirmed continuation above $566 on >7M volume with positive MACD.
30 wins · 11 losses · 3 pushes in 44 scored verdicts How this is scored
Free accounts read most reports by the next trading session, every report within 7 days — subscribers read it the same day.
Create a free account-5.1%
Report archive
Subscribe to read
Subscribe to read
last 30 of 49 reports30 wins · 11 losses · 3 pushes in 44 scored verdicts-0.10% avg move
$10,000 → $9,494
-6.7%
$10,000 → $9,334
too few trades to judge — 1 round trip, 0 profitablein the market 3 of 6 sessionsmax drawdown -6.7%simulated 2 Oct – 9 Oct 20265 newer calls are locked
Simulated with a notional $10,000, fills at the next session's open, no commissions or slippage, split- and dividend-adjusted prices. Not a return forecast. How this is simulated
Subscribe to read
Subscribe to read
Subscribe to read
Trim AMAT to 50% of benchmark weight immediately given cycle-peak configuration (record Q3'26 revenue $9.12B, 33.7% operating margins, 41% TTM ROE) paired with decaying momentum and unsupportive macro conditions (96% probability of no 2026 Fed cuts, multi-year high yields). Maintain 50% residual with hard stop at $489 (50 SMA), and do not initiate fresh longs until either a cyclical reset to $415-432 zone or confirmed continuation above $566 on >7M volume with positive MACD.
All three analysts independently converge on HOLD for AMAT, with the 10/06 reflection directly binding against holding full weight at peak multiple (28x forward P/E) into a binary Q4 FY26 catalyst. Execute a 15-20% tactical trim into any relief bounce at $520-540 to capture partial gains from the +27% rally while preserving 80-85% core thesis participation; hard stop at $479 daily close with discretionary reassessment if price closes below $499 (10 EMA) on expanding volume for two consecutive sessions.
Maintain AMAT at current weight with HOLD rating; do not add at $530 or chase the 27.7% recovery ahead of the Q4 FY26 binary catalyst in mid-November. Hard stop at $487 daily close (50 SMA) with discretionary reassessment trigger at $499 (10 EMA) on expanding volume for two consecutive sessions. Trim ladder: 25% at $558 (upper Bollinger), 25% at $600, remaining 50% with trailing stop at $560. All new capital deployment deferred until post-Q4 earnings print; hard macro exit if 10Y sustains above 5.10% for 3+ consecutive daily closes.
Upgraded to Overweight with a scaled add of 25-33% of intended new capital at current levels ($542.28), with pre-staged additional adds at $507 and $487 on pullbacks, capped at 5% total portfolio weight. Hard stop set at $428 (200 SMA daily close), with trim zones at $552-570 and $580-600; binary catalyst is Q4 FY26 earnings in late November where bull case requires revenue ≥$9.5B with gross margin >50%.
Maintain AMAT at current weight (≤5% portfolio cap) with no new additions at ~$540, as the +27% rally in 12 sessions combined with upper Bollinger Band tag, RSI 69, and declining volume creates poor entry risk/reward. Hard structural stop remains at $487 (50 SMA) with discretionary reassessment if price closes below $499 (10 EMA) on expanding volume for two consecutive sessions; add only on pullback to $487-$499 buy zone or after Q4 FY26 earnings confirmation.
Maintain AMAT at 3-4% portfolio cap with no new additions at current elevated levels; trim 20-25% into any push to $530-540 to lock in gains from the +27.4% rally. Hard stop at $470 daily close protects against downside, while re-engagement is warranted on either a pullback to $460-490 with RSI reset, or post-Q4 FY26 earnings confirmation of gross margin >50% and sequential revenue growth. Hedge with $480 January puts (2-3% of position cost) given beta 1.60 in a 4.8% 10Y environment.
Trim 15-20% of AMAT position immediately at market (~$511), not contingent on rallies that may not materialize given 1.6-beta volatility. Hold core 80-85% of position intact with hard stop at $480 daily close. Re-engagement framework: add back on confirmed close above $516 with ≥8M share volume AND 10Y rolling below 5%; reassess toward Hold/Overweight at Q4 FY26 print (mid-November).
Maintain AMAT at current exposure without adding at $512 levels given parabolic recovery into overhead supply; hard stop at $423 daily close (200 SMA break) with re-engagement on constructive pullback to $475-$488. Pre-commit to trim 25-33% into the $533-$546 overhead supply zone while sizing the position to survive a 30-35% drawdown without impairing the portfolio. Full reassessment at Q4 FY26 earnings mid-November as the binary catalyst for the receivables-vs-revenue interpretation.
Maintain AMAT at neutral weighting with defined risk bands while awaiting Q1 FY27 catalyst resolution within 4-8 weeks. The HOLD rating reflects convergence across all three analysts despite differing rationales—fundamentals remain elite but cyclically elevated, technical improvement unconfirmed, and macro tightening creates structural multiple compression risk given beta 1.60. Protective puts at $440 strike for concentrated positions (>5% portfolio) provide hedging; hard stop triggers at $415 daily close (200 SMA breach).
Analysts recommend a phased Overweight position in AMAT, deploying ~40% of intended exposure at current ~$485 levels with additional tranches contingent on the 50 SMA reclaim at $489.98 and pullback entry zones; hard stop at $455 (~6% downside), with trim targets at $540 and $641 representing 11-32% upside, supported by structural improvements including services growth, elite margins, and AI capex positioning.
Maintain AMAT at HOLD with $410 hard stop as the macro headwinds (10Y at ~5%, 92% Polymarket hike probability) and deteriorating technical structure (below 50 SMA at $491.48, MACD line at -9.13) outweigh the bounce from the 200 SMA defense on 14.3M shares of 2x-ADV volume. Tiered re-engagement framework targets $440-455 (constructive), $494-500 (first confirmation), and $510+ (full OW) while monitoring the binary Q4 FY26 earnings catalyst in mid-November.
Maintain AMAT at neutral benchmark weighting with tiered re-engagement architecture—do not add aggressively at $474 or trim prematurely. Fundamentals (record $9.12B Q3 revenue, 41% ROE, AGS +22% YoY) preclude selling, while technical setup (below declining 50 SMA at $493.58, MACD line at -11.64, single-wick 200 SMA test) and hawkish macro (97% no-cut probability, 10Y at 5%) preclude adding. Q4 FY26 earnings mid-November is the binary catalyst.
Maintain AMAT position at $472 with a HOLD rating; business fundamentals (record $9.12B revenue, 41% ROE, AGS +22% services growth) prevent selling while bearish technical setup (below 50 SMA at $495.99) and hawkish macro (96% no-cut probability) prevent adding. Define hard stop at $405 daily close, working stop at $438; add triggers at $500 breakout or $449-452 pullback on declining volume; full reassessment at Q4 FY26 earnings mid-November as the binary resolving catalyst.
Maintain AMAT at $464 with a HOLD rating, as the probability-weighted expected value of +0.32% confirms a balanced risk/reward setup. Define trim triggers at $480-498 overhead resistance and add triggers at $408-416 (200 SMA with reversal confirmation) or $498 break with MACD cross; hard stop at $400 weekly close. Q4 FY26 earnings in mid-November is the binary resolving catalyst.
Initiate AMAT at OVERWEIGHT with a 33/25/25 phased scale-in architecture, deploying 83% of model weight across three confirmation tiers: 33% at current $435-450 (limit $445), 25% on close above $454 with volume ≥12M shares, and 25% on close above $500 with MACD bullish cross; hard stop at $411 on closing basis with a 0.50% NAV tail hedge via SOX puts to neutralize the 1.60 beta risk into a hawkish Fed regime.
Maintain AMAT at benchmark weight with HOLD rating. The 200 SMA at $414.57 is being tested at $417 (0.6% above), which is precisely the regime where the magnitude-miscalibration constraint and 7-for-7 floor-hold pattern mandate Hold over Underweight. Define a tactical add-on zone at $400-410 with RSI >40, MACD histogram positive for 3 sessions, and close above 10 EMA $438 as confirmation; hard stop at $390 on closing basis.
Underweight AMAT with 20-25% trim recommended in two tranches post-FOMC catalyst; hard stop at $400 daily/$405 weekly close on retained core. Technical structure is broken (MACD histogram at -2.38, RSI at 33, only $1.64 margin above 200 SMA), but FOMC timing risk and magnitude-miscalibration lessons from prior calls constrain aggressive pre-catalyst selling.
Underweight rating with a 30% trim of AMAT exposure justified by the compressed $13 cushion above the 200-SMA at $411, hostile macro regime, and contemporaneous earnings quality deterioration including a 10% QoQ net income decline despite record revenue. The retained 50-60% core position carries a hard protective stop at $405 (weekly close basis) and full exit trigger at weekly close below $411, with Q4 FY26 earnings in mid-November as the binary resolving catalyst.
Initiate Overweight in AMAT with a staged approach: start with a 0.75% NAV tranche in the $435–$445 zone, using a $405 hard stop and $425 early-warning de-risking trigger. Scale to 1.25–1.50% maximum on structural confirmation (tranche 2 above $461 on 10 EMA and positive MACD, tranche 3 above $475 on volume), then trim 25–30% at the $516 50 SMA reclaim and again at $600.
Maintain existing AMAT position; do NOT initiate fresh capital. Replace covered-call monetization at $480-$500 strikes with a collar or deep OTM put structure to avoid the call-overhang alpha cap. Add trigger tightened to $420-$435 with positive MACD histogram + volume confirmation. Hard structural stop at $410 (200 SMA) with $421 early-warning de-risking (reduce by ~1/3). HOLD preserves upside optionality if basing resolves higher while limiting damage if it doesn't; Q4 FY26 earnings mid-November remains the binary resolving catalyst.
Maintain AMAT at benchmark weight (Hold) with a $410 structural stop as the secular thesis invalidation point, using a $421 early-warning de-risking trigger to reduce by ~1/3 before full exit. Trimming should only occur on confirmed volume close above $520 with MACD bullish cross, sized at 20-25%, not mechanically into resistance.
Trim approximately 40% of AMAT via limit orders at $472-475 given asymmetric risk/reward with no margin of safety above the $462 conservative fair value, revenue/EPS divergence, and hostile macro backdrop; hold residual 60% to preserve WFE cycle participation with hard stop at $420 and mental floor at $408. Q4 FY26 earnings in mid-November serves as the binary resolution catalyst for the margin compression thesis.
Maintain AMAT at current levels with neither aggressive addition nor trimming. Hold the $407 structural stop (200 SMA floor), not the tighter $435, and wait for confirmation via either a $420-435 pullback with reversal signals or a decisive $530 reclaim on volume >10M shares before committing fresh capital.
Initialize a staggered Overweight position in AMAT via a 0.40–0.50% NAV starter tranche at the $440–$475 weakness zone, reserving an additional 0.35% for confirmation on a daily close above ~$473 with RSI > 50, and capping total exposure at 1.75–2.00% NAV until a weekly close above ~$533 with RSI > 55.
Trim AMAT by 25-30% over 3-4 weeks via three tranches (40% at $445-455, 40% at $420-430 capitulation zone, 20% on VWMA reclaim at $480), reducing from ~1.75% to ~1.2-1.4% equity book weight; re-evaluate to Hold only if daily close above $493 with contracting MACD histogram, with hard stop/invalidation at $400 daily close (200 SMA break).
Trim AMAT by 40-50% (reducing from 3-3.5% benchmark to 1.5-2% equity-book weighting) while retaining a 50-55% structural core, with hard invalidation below the rising 200 SMA at $402.89. Execute in tranches: first at current $438-445, second on relief bounce to $472-501 cluster, third on confirmed weakness through $465. Price target is $500.0, with Q4 FY26 earnings (mid-November) as the binary resolution event.
The analyst maintains a HOLD rating on AMAT at $441.85 given the essentially neutral probability-weighted expected value (+0.20%), despite acknowledging bearish technical signals (MACD -20.19, RSI 34.34, 200 SMA test imminent at $401.85) and working-capital deterioration ($1.4B receivables spike, FCF collapsing from $2.05B to $210M). The recommendation prescribes a modest 15-25% proactive trim if above target weight and covered-call overlay at $520-$530 strikes (60-90 DTE), with hard invalidation at $399 and reassessment scheduled for the 200 SMA test and Q4 FY26 earnings in mid-November.
Maintain AMAT at current sizing without adding; trim 25–30% only if AMAT retakes $488 but fails to hold it for two sessions with a still-negative MACD histogram. A daily close below $400 on heavy volume triggers a more aggressive trim, with $395 as the hard stop. Reassess at mid-November Q3 earnings, where FCF recovery above $1.5B with stable China revenue could support upgrading to Overweight.
AMAT maintains HOLD at $461 as neither the aggressive analyst's spot-add case nor the conservative analyst's trim case is compelling enough to overcome documented magnitude-miscalibration patterns and 1.62 beta risk into a Q4 earnings binary. The portfolio manager will deploy a covered-call overlay at $520–$530 strikes (60–90 DTE) if any relief bounce materializes toward $488 on volume ≥15M shares, and will let mid-November Q4 FY26 earnings resolve the bull-bear ambiguity around the $10.25B guide.
Maintain AMAT at ~$482 with no additions into the unconfirmed basing structure. Trim 25-35% of position on post-Jackson Hole, volume-confirmed strength (≥15M shares) into the $494–$513 zone and $553, while deploying a covered-call overlay at $520–$530 strikes (60-90 DTE) on any relief bounce to neutralize tail risk without forced directional execution.
Portfolio Manager sets AMAT at Underweight, directing a decisive 50–60% trim at $485–500 while retaining a calibrated 30–35% core—the Neutral Analyst's middle ground that survives a 200 SMA test at ~$398 with -17% drawdown versus meaningful capture on a 10 EMA reclaim at $497.58. The Trader's "Sell" label is rejected as internally inconsistent with a 40–50% retained core and as replicating the documented magnitude-miscalibration pattern that produced only token alpha (-0.8%, -1.7%, -1.4%) on six prior Underweight calls; instead, a collar overlay (sell $580–600 calls to finance $400–420 puts, 30–45 DTE) replaces the $395 hard stop deemed a "trap." Re-engagement is staged across three price zones ($420–435, $398–420, >$497.58) with weekly technical reviews and full reassessment at Q4 FY26 earnings (mid-November).
Hold AMAT while selling covered calls at $520-$530 strike for September/October expiry (60-90 DTE) on any relief bounce toward the 10 EMA at $501, preserving the existing core position without fresh directional trimming. Hard stop at $410 (above 200 SMA at $397) limits downside, with full reassessment scheduled at Jackson Hole (Aug 28) and Q4 FY26 earnings (mid-November).
Maintain current AMAT position with no aggressive adding or trimming at ~$484, as the structural bull case (41.1% ROE, 49.4% gross margins, near-zero net debt, record $9.12B quarter) argues against selling into a 33% drawdown, but unfavorable near-term risk/reward (~5-6% upside to 10 EMA at $506 vs ~18% downside to 200 SMA at $395) and unconfirmed technical basing (MACD expanding negative at -12.90, RSI 41.82 not oversold) argue against adding. Deploy a tiered scaling plan triggered by technical confirmation, paired with covered calls for carry.
Trim AMAT 40-50% via staged execution at $492, $500-510, and $460/50 SMA failure, reducing from ~100% benchmark weight to ~50-60% while maintaining a 0.5% core with a collar hedge (sell $580-600 calls to finance $470-480 puts, 30-45 DTE). The technical breakdown (four failed 50 SMA tests, lower highs/lows for 30 sessions) and poor risk/reward (~14% upside to $560 vs -6.5% to $460) warrant Underweight; franchise quality prevents full capitulation.
Trim AMAT by 40-50% over 1-3 months through staged sales at $496, $500-510, and $465/50 SMA rejection, reducing portfolio weight to ~50-60% of benchmark—the bear case (90% FCF collapse, 27x valuation premium vs peers, confirmed technical breakdown) warrants substantial reduction but structural franchise quality (40% ROE, $8.24B cash) prevents capitulation. Re-enter only upon BOTH 50 SMA reclaim at $555-565 with rising slope AND MACD positive cross with RSI >50; hard invalidation at $436 weekly close (reduce to 0.5%) or $393 weekly close (full exit).
Trim 30-40% of AMAT exposure given confirmed bearish breakdown below $500 with deteriorating fundamentals (FCF -57% over two years, $1.4B AR build), reducing to underweight versus chip equipment group while maintaining residual exposure hedged via a collar structure; hard stop at $460 with full exit triggers at $436 and $391.
Reduce AMAT by 40-45% in tranches targeting 60-70% of benchmark weight in tech/semis, executing ~20% on first $525 test with volume, 10-15% on second failed test, and remaining 10-15% post-Jackson Hole (Aug 28); stop remains at $436 (July 29 low), with collar hedging via selling $580-600 calls to fund $470-480 puts at 30-45 DTE.
Reduce AMAT exposure by 30-50% into the $540-560 bounce zone using tranche selling, avoiding new longs at $535.31, with full liquidation signaled only on weekly close below $436.45. Re-enter only if AMAT reclaims $559.56 with confirmed volume and momentum signals, or on pullback to $465-490 offering ~3:1 risk/reward.
Maintain current AMAT position at 0.5-0.7% portfolio weight at $507 — neither adding nor trimming. Fundamentals (40% ROE, near-zero net debt, $2.57B deferred revenue, AI capex tailwind) justify ownership, but technicals (two confirmed lower highs at 50 SMA, MACD line at -7.50, RSI 44.94 in bearish territory, -5.1% breakdown on elevated volume) argue against fresh capital deployment. The Q2 FY26 earnings print in late October is the fundamental re-rating catalyst; pre-committed decision levels ($527 add trigger, $464.80 trim trigger) govern interim action.
Trim AMAT to 60-65% of benchmark weight (35-45% reduction) using a staged approach: one-third at market if below $545, one-third into 50 SMA retest at $555-565, final third into $510-520 weakness or retest failure; employ a collar hedge (sell $580-600 calls, buy $470-480 puts, 30-45 DTE) to neutralize binary-event tail risk rather than relying on position size alone; Underweight rating is supported by technical deterioration (below 50 SMA at $558, negative MACD) and stretched valuation (31x forward P/E, 17.75x book) but avoids full Sell given intact 200 SMA, fortress balance sheet, and four-call magnitude-miscalibration history that argues against over-trimming a name that repeatedly holds structural support.
Maintain AMAT at ~1% portfolio weight with a $465.75 hard stop; trim 10-15% of position if price reaches $587 (Bollinger upper band) ahead of Thursday's earnings, but do not add fresh capital pre-print given 51.6x P/E and 1:3 earnings asymmetry. Post-earnings, add back to 1.5% weight on a single confirmed close above $558 with volume >7M shares AND clean beat-and-raise — not two consecutive closes, correcting the August 11 over-conservatism. Exit immediately to underweight on China export-control escalation at the Thursday/Friday open.
Maintain the AMAT position at ~1% portfolio weight ahead of clustered Q3 FY26 earnings and CPI catalysts within 48-72 hours. The structural bull case (39.7% ROE, fortress balance sheet, TSMC +44.7% revenue growth) argues against selling, while undefined technical regime (price below 50 SMA at $556, MACD line at -9.3, elevated 6.9% daily ATR) argues against buying. Use a protective put hedge at $470 strike December expiration to cap tail risk without sacrificing upside participation.
Trim 40-50% of AMAT exposure in tranches ahead of the Aug 10-14 earnings window, using a collar hedge (sell $580-600 calls to finance $470-480 puts, 30-45 DTE) instead of standalone puts to avoid IV crush. Maintain a hard stop at $436-450 (2x ATR-adjusted), retain 50-60% core allocation at no more than 60% of normal cyclical-equipment sizing, and re-enter on two-of-three conditions.
Reduce AMAT exposure by 40-50% through staged tranches over 2-5 sessions rather than at a single price point, retaining a 50-60% core position sized at 60% of normal allocation. Execute trims at ~$539 (one-third), $545-555 zone (one-third), and either above $560 on volume ≥6M shares or down to $510-520 (final third), with hard stop at $495 and re-entry target at $420-470. The 90% FCF collapse, 50x trailing multiple at peak margins, and three stacked binary catalysts within two weeks justify the reduction, while the $8.24B cash balance and accelerating revenue support holding meaningful core exposure.
Get the daily brief — how yesterday's calls actually scored, in your inbox before the open — free with a TraderPunk account.
Create a free accountAlready have one? Sign in to subscribe.